Prostatic Neoplasms: all 6,484 studies

Page 18 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.

• 68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate CancerCompletedNCT03113617Phase 2Results posted
• Applications of Dual Energy CT in Patients With Osseous Metastases From Castrate-resistant Prostate CancerTerminatedNCT03111914Not applicableResults posted
• Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate CancerCompletedNCT03103321Phase 3Results posted
• A Study to Examine the Effectiveness of Aspirin and/or Vitamin D3 to Prevent Prostate Cancer ProgressionCompletedNCT03103152Phase 2/3Results posted
• Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate CancerCompletedNCT03098836Phase 2Results posted
• Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPCCompletedNCT03093428Phase 2Results posted
• A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate CancerTerminatedNCT03093272Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate CancerCompletedNCT03085095Phase 3Results posted
• Validation of FACBC for Detection of Metastasis Among High-risk Prostate Cancer Patients With Presumed Localized DiseaseCompletedNCT03081884Phase 2Results posted
• Trial of NanoPac® Focal Therapy in Subjects With Prostate CancerCompletedNCT03077659Phase 2Results posted
• Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate CancerCompletedNCT03072238Phase 3Results posted
• Trial of ADT and SBRT Versus SBRT for Intermediate Prostate CancerTerminatedNCT03056638Phase 3Results posted
• Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal BiopsyCompletedNCT03044197Not applicableResults posted
• A Study of Definitive Therapy to Treat Prostate Cancer After ProstatectomyCompletedNCT03043807Phase 2Results posted
• Phase I Dose-escalation Study of Fractionated 177Lu-PSMA-617 for Progressive Metastatic CRPCCompletedNCT03042468Phase 1/2Results posted
• Lutetium-177 (Lu177) Prostate-Specific Antigen (PSMA)-Directed EndoRadiotherapyTerminatedNCT03042312Phase 2Results posted
• Urology of Virginia Case SeriesCompletedNCT03035487Not applicableResults posted
• A Study of ELIGARD® in Hormone-dependent Prostate Cancer PatientsCompletedNCT03035032Phase 4Results posted
• VMAT for Dominant Intraprostatic LesionCompletedNCT03030625Not applicableResults posted
• A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane RegimenCompletedNCT03016312Phase 3Results posted
• Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADTCompletedNCT03007732Phase 2Results posted
• Trial of Rad-223 Activity in Asymptomatic Patients With mCRPC While on Abiraterone or Enzalutamide Besides AR-V7 StatusCompletedNCT03002220Phase 2Results posted
• Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate CancerTerminatedNCT02995330Phase 1Results posted
• Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSACompletedNCT02989623Not applicableResults posted
• Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer PatientsCompletedNCT02987829Phase 1/2Results posted
• Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)CompletedNCT02987543Phase 3Results posted
• A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)CompletedNCT02985957Phase 2Results posted
• Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair DeficienciesTerminatedNCT02985021Phase 2Results posted
• Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate CancerCompletedNCT02981368Phase 2/3Results posted
• Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot StudyCompletedNCT02967458Phase 2Results posted
• One-year, Open Extension to Evaluate the Treatment of Patients With Castration-Resistant Prostate Cancer With YONSA™CompletedNCT02962284Phase 2Results posted
• Vessel Sparing Prostate Radiation TherapyCompletedNCT02958787Phase 2Results posted
• Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer SurvivorsCompletedNCT02957357Results posted
• Platelet Rich Plasma During Radical ProstatectomyCompletedNCT02957149Not applicableResults posted
• A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene DeficiencyCompletedNCT02952534Phase 2Results posted
• Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation TherapyTerminatedNCT02946996Phase 2Results posted
• PROSTVAC in Combination With Nivolumab in Men With Prostate CancerCompletedNCT02933255Phase 1/2Results posted
• Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate CancerActive, not recruitingNCT02923180Phase 2Results posted
• Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy PatientsCompletedNCT02919111Phase 2/3Results posted
• Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate CancerCompletedNCT02918968Phase 4Results posted
• Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor MalignanciesTerminatedNCT02913131Phase 1/2Results posted
• Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate CancerTerminatedNCT02911922Not applicableResults posted
• PACCT: Partnering Around Cancer Clinical TrialsCompletedNCT02906241Not applicableResults posted
• Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing ProstatectomyCompletedNCT02903368Phase 2Results posted
• Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)CompletedNCT02903160Phase 2Results posted
• Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate CancerActive, not recruitingNCT02893917Phase 2Results posted
• Consensus Method to Evaluate the Conformity of Prescription of a ChemotherapyCompletedNCT02882178Results posted
• Hypofractionation Proton Beam Therapy With Concurrent Treatment of Prostate and Pelvic Nodes for Prostate CancerCompletedNCT02874014Phase 2Results posted
• An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair AnomaliesCompletedNCT02854436Phase 2Results posted
• A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomyCompletedNCT02849990Phase 2Results posted
• Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate CancerTerminatedNCT02844582Phase 2Results posted
• FACBC Prostate Therapy ResponseCompletedNCT02830880Phase 2Results posted
• Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing SurgeryCompletedNCT02830165Not applicableResults posted
• Expectations and Priorities of Elderly Patients for a First Medical Treatment for CancerCompletedNCT02821793Results posted
• Quell Opioid Reduction and Pain Relief in Patients With CancerTerminatedNCT02809846Not applicableResults posted
• A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active SurveillanceCompletedNCT02799745Phase 2Results posted
• Durvalumab With or Without Tremelimumab in Metastatic Castration Resistant Prostate CancerCompletedNCT02788773Phase 2Results posted
• Study of Pembrolizumab (MK-3475) in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)(MK-3475-199/KEYNOTE-199)CompletedNCT02787005Phase 2Results posted
• Genomics in Michigan Impacting Observation or RadiationCompletedNCT02783950Not applicableResults posted
• AASUR in High Risk Prostate CancerCompletedNCT02772588Phase 2Results posted
• Adjuvant PROSTVAC-V/F in Subjects at High Risk for Relapse After Radical ProstatectomyTerminatedNCT02772562Phase 2Results posted
• Apalutamide and Leuprolide in Intermediate and High-risk Prostate CancerCompletedNCT02770391Phase 2Results posted
• Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung CancerTerminatedNCT02769962Phase 1/2Results posted
• Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate CancerTerminatedNCT02766478Phase 2Results posted
• Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone MetastasesTerminatedNCT02758132Phase 2Results posted
• Targeted Fusion Biopsy of the ProstateCompletedNCT02744534Phase 2Results posted
• A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT02737332Phase 2Results posted
• Vitamin D and Prostate Cancer: A Clinical Study Enrolling Subjects Undergoing ProstatectomyCompletedNCT02726113Phase 2Results posted
• A Study of Definitive Therapy to Treat Prostate CancerCompletedNCT02716974Phase 2Results posted
• Open-Label Safety Extension Study in Patients Who Have Previously Participated and Have Benefited From LMIS 50 mgCompletedNCT02712320Phase 3Results posted
• A Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT02711956Phase 1/2Results posted
• Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesTerminatedNCT02711137Phase 1/2Results posted
• Miami Membrane for Potency (MMEP) TrialTerminatedNCT02710422Phase 2Results posted
• Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate CancerTerminatedNCT02685267Phase 2Results posted
• Pilot Study Evaluating the Role of Histopathology Correlation in Treatment PlanningCompletedNCT02681614Not applicableResults posted
• Stereotactic Body Radiation for Prostate OligometastasesCompletedNCT02680587Phase 2Results posted
• 18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer TreatmentCompletedNCT02680041Phase 3Results posted
• 68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing SurgeryCompletedNCT02678351Phase 2/3Results posted
• 68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial TreatmentCompletedNCT02673151Phase 2/3Results posted
• A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular DiseaseTerminatedNCT02663908Phase 3Results posted
• Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate CancerCompletedNCT02649855Phase 2Results posted
• Prostvac in Patients With Biochemically Recurrent Prostate CancerCompletedNCT02649439Phase 2Results posted
• Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate CancerTerminatedNCT02648919Phase 2Results posted
• Ibrutinib as Neoadjuvant Therapy in Localized Prostate CancerCompletedNCT02643667Phase 2Results posted
• A Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR)TerminatedNCT02616185Phase 1Results posted
• Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer PatientsCompletedNCT02614859Phase 2Results posted
• Evaluation of Gallium-68-HBED-CC-PSMA Imaging in Prostate Cancer PatientsCompletedNCT02611882Phase 2Results posted
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 (Alobresib) as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate CancerTerminatedNCT02607228Phase 1/2Results posted
• Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7CompletedNCT02601014Phase 2Results posted
• Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 PathwayCompletedNCT02598895Phase 2Results posted
• Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone MetastasesTerminatedNCT02582749Phase 2Results posted
• Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcerCompletedNCT02578940Phase 3Results posted
• Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate CancerTerminatedNCT02565901Phase 1/2Results posted
• North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS)CompletedNCT02564120Results posted
• Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate CancerTerminatedNCT02560051Phase 2Results posted
• 68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate CancerCompletedNCT02559115Phase 2Results posted
• Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate CancerCompletedNCT02555397Phase 1Results posted
• Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma ExpressionTerminatedNCT02555189Phase 1/2Results posted
• Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid TumorsCompletedNCT02552121Phase 1/2Results posted
• Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate CancerActive, not recruitingNCT02522715Phase 1/2Results posted

← Prostatic Neoplasms overview